Enlivex Therapeutics (ENLV) Stock Chart & Stock Price History → [FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks (From Crypto 101 Media) (Ad) Free ENLV Stock Alerts $1.40 0.00 (0.00%) (As of 05/17/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainSEC FilingsShort InterestSocial Media Enlivex Therapeutics Stock Price Performance5 Day Performance-6.00%1 Month Performance-4.73%3 Month Performance-57.53%6 Month Performance-18.97%Year-To-Date Performance-47.78%1 Year Performance-48.72% Receive ENLV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Enlivex Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad InvestorPlaceElon’s New Device is About to Shock the WorldUsing this device you see above… Elon Musk just tested a new type of A.I. that according to Wired Magazine will usher in… “The next step in human evolution.” Click here to see the details because there’s a lot of money at stake. ENLV Stock Chart for Saturday, May, 18, 2024 ENLV Chart by TradingView Enlivex Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/16/2024$1.42$1.40-1.41%$1.43$1.3915,707 shs$26.04 million05/15/2024$1.45$1.42-2.07%$1.48$1.3771,639 shs$26.41 million05/14/2024$1.47$1.45-1.36%$1.52$1.3766,597 shs$26.97 million05/13/2024$1.50$1.47-2.00%$1.55$1.4232,686 shs$27.34 million05/10/2024$1.52$1.50-1.32%$1.53$1.4340,709 shs$27.90 million05/09/2024$1.57$1.52-3.18%$1.57$1.5123,343 shs$28.27 million Get the Latest News and Ratings for ENLV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Enlivex Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/08/2024$1.57$1.57$1.62$1.5347,525 shs$29.20 million05/07/2024$1.57$1.57$1.63$1.5443,454 shs$29.20 million05/06/2024$1.62$1.57-3.09%$1.62$1.5368,778 shs$29.20 million05/03/2024$1.62$1.62$1.66$1.5245,802 shs$30.13 million05/02/2024$1.61$1.62+0.62%$1.76$1.53281,469 shs$30.08 million05/01/2024$1.67$1.61-3.59%$1.64$1.5175,057 shs$29.90 million04/30/2024$1.66$1.67+0.60%$1.70$1.60106,632 shs$31.01 million04/29/2024$1.44$1.66+15.28%$1.84$1.47474,649 shs$30.83 million04/26/2024$1.45$1.44-0.69%$1.49$1.4458,077 shs$26.74 million04/25/2024$1.50$1.45-3.33%$1.49$1.4452,572 shs$26.93 million04/24/2024$1.32$1.50+13.64%$1.53$1.33125,806 shs$27.86 million04/23/2024$1.27$1.32+3.94%$1.37$1.3048,007 shs$24.51 million04/22/2024$1.32$1.27-3.79%$1.30$1.2451,524 shs$23.58 million04/19/2024$1.40$1.32-5.71%$1.39$1.23108,601 shs$24.51 million04/18/2024$1.48$1.40-5.41%$1.52$1.3992,329 shs$26.00 million04/17/2024$1.45$1.48+2.07%$1.56$1.40388,666 shs$27.48 million04/16/2024$1.30$1.45+11.54%$1.46$1.32405,672 shs$26.92 million04/15/2024$1.58$1.30-17.72%$1.52$1.15841,211 shs$24.14 million04/12/2024$1.83$1.58-13.66%$1.93$1.331.02 million shs$29.34 million04/11/2024$3.98$1.83-54.02%$2.24$1.652.79 million shs$33.98 million04/10/2024$4.08$3.98-2.45%$4.19$3.9287,758 shs$73.91 million04/09/2024$4.10$4.08-0.49%$4.21$4.02127,386 shs$75.77 million04/08/2024$4.00$4.10+2.50%$4.20$3.83124,344 shs$76.14 million04/05/2024$3.76$4.00+6.38%$4.04$3.54122,866 shs$74.28 million04/04/2024$4.31$3.76-12.76%$4.43$3.74265,122 shs$69.82 million04/03/2024$4.04$4.31+6.68%$4.59$4.00191,707 shs$80.04 million04/02/2024$4.00$4.04+1.00%$4.17$3.79142,863 shs$75.02 million04/01/2024$3.79$4.00+5.54%$4.17$3.75125,141 shs$74.28 million03/29/2024$3.79$3.79$3.98$3.70126,662 shs$70.38 million03/28/2024$3.86$3.79-1.81%$3.98$3.70126,660 shs$70.38 million03/27/2024$3.91$3.86-1.28%$3.94$3.7058,893 shs$71.68 million03/26/2024$4.11$3.91-4.87%$4.18$3.80127,360 shs$72.61 million03/25/2024$3.68$4.11+11.68%$4.15$3.82157,234 shs$76.32 million03/22/2024$3.59$3.68+2.51%$3.85$3.5972,792 shs$68.34 millionObama’s Forever Term [exposed] (Ad)America’s Last Election New documentary, America’s Last Election, reveals the true (and terrifying) story of how the D.C. establishment has engineered a brutal new crisis that could hand them permanent power. Power they will use to reshape America to their dark, dystopian vision.Start streaming it now at no cost here03/21/2024$4.02$3.59-10.70%$3.96$3.37148,048 shs$66.67 million03/20/2024$4.07$4.02-1.23%$4.05$3.8730,029 shs$74.65 million03/19/2024$4.18$4.07-2.63%$4.24$4.0238,684 shs$75.58 million03/18/2024$4.11$4.18+1.70%$4.27$3.9590,961 shs$77.62 million03/15/2024$4.12$4.11-0.24%$4.20$4.0516,308 shs$76.32 million03/14/2024$4.30$4.12-4.19%$4.30$3.81129,929 shs$76.51 million03/13/2024$4.17$4.30+3.12%$4.35$4.1795,925 shs$79.85 million03/12/2024$3.70$4.17+12.70%$4.37$3.73207,167 shs$77.42 million03/11/2024$3.95$3.70-6.33%$4.24$3.58160,259 shs$68.71 million03/08/2024$3.27$3.95+20.80%$4.32$3.43254,654 shs$73.35 million03/07/2024$3.36$3.27-2.68%$3.43$3.2561,393 shs$60.72 million03/06/2024$3.24$3.36+3.70%$3.43$3.2041,908 shs$62.40 million03/05/2024$3.42$3.24-5.26%$3.40$3.1630,101 shs$60.17 million03/04/2024$3.21$3.42+6.54%$3.47$3.1980,132 shs$63.51 million03/01/2024$3.11$3.21+3.38%$3.40$3.13114,110 shs$59.61 million02/29/2024$2.92$3.11+6.34%$3.20$2.9994,527 shs$57.66 million02/28/2024$3.06$2.92-4.58%$3.09$2.9139,155 shs$54.22 million02/27/2024$3.00$3.06+2.00%$3.19$2.94119,972 shs$56.81 million02/26/2024$3.04$3.00-1.32%$3.31$2.7855,667 shs$55.71 million02/23/2024$3.15$3.04-3.49%$3.30$2.8475,504 shs$56.45 million02/22/2024$3.22$3.15-2.17%$3.22$3.0629,493 shs$58.50 million02/21/2024$3.27$3.22-1.53%$3.27$3.1052,263 shs$59.80 million02/20/2024$3.32$3.27-1.51%$3.50$3.2067,840 shs$60.72 million02/19/2024$3.32$3.32$3.42$3.1342,400 shs$61.65 million02/16/2024$3.21$3.32+3.43%$3.42$3.1342,429 shs$61.65 million Related Companies: NNVC Stock Chart JAN Stock Chart BIOR Stock Chart ACST Stock Chart UBX Stock Chart ONCT Stock Chart DRRX Stock Chart LPCN Stock Chart ITRM Stock Chart FBRX Stock Chart Receive ENLV Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Enlivex Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ENLV) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingElon’s New Device is About to Shock the WorldInvestorPlaceMake this ONE trade on Tuesday at 2 p.m. EST!Monument Traders AllianceA once-in-a-century investment opportunityStansberry Research[URGENT] DO NOT Touch These AI Stocks!Weiss RatingsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressHe Is Giving Away BitcoinCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Enlivex Therapeutics Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.